Tumor necrosis factor-α, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis

Journal of Neuroimmunology

Volumn 71, Issue 1-2, 1996, Pages 191-198

  Matusevicius, Darius ^a   Navikas, Vaidrius ^a   Palasik, Witold ^a   Pirskanen, Ritva ^b   Fredrikson, Sten ^a   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

interleukin 10; interleukin 12; interleukin 6; lymphotoxin; Myasthenia gravis; perf orin; tumor necrosis factor

Indexed keywords

CHOLINERGIC RECEPTOR; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LYMPHOTOXIN; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LYMPHOTOXIN-ALPHA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYASTHENIA GRAVIS; NERVOUS SYSTEM DISEASES; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, NICOTINIC; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030561139     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00152-X     Document Type: Article

References (39)

1. Ahlberg R.E., Pirskanen R., Lefvert A.K. Defective T lymphocyte function in nonthymectomized patients with myasthenia gravis. Clin. Immunol. Immunopath. 60:1991;93-105.
2. Anderson J.T., Cornelius J.G., Jarpe A.J., Winter W.E., Peck A.B. Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event Autoimmunity. 15:1993;113-122.
3. Aste-Amezaga M., D'Andrea A., Kubin M., Trinchieri G. Cooperation of natural cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol. 156:1994;480-492.
4. Cohen-Kaminsky S., Devergne O., Delattre R.M., Klingel-Schmitt I., Emilie D., Galanaud P., Berrih-Aknin S. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia. Eur. Cytokine Netw. 4:1993;121-132.
5. Confalonieri P., Antozzi C., Cornelio F., Simonci O., Mantegazza R. Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-γ and tumor necrosis factor-α levels in patients' serum. J. Neuroimmunol. 48:1993;33-36.
6. Deibler G.E., Martensson R.E., Kies M.V. Large scale preparation of myelin basic protein from central nervous tissue of several animal species. Prep. Biochem. 2:1972;139-165.
7. Gray P.W., Aggarwal B.B., Benton C.V., Bringman T.S., Henzel W.J., Jarrett J.A., Leung D.W., Moffat B., NG P., Svedersky L.P., Palladino M.A., Nedwin G.E. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature. 312:1984;721-724.
8. Gu D., Wogensen L., Calcutt N.A., Xia C., Zhu S., Merlie J.P., Fox H.S., Lindstrom J., Powell H.C., Sarvetnick N. Myasthenia gravis-like syndrome induced by expression of interferon-γ in the neuromuscular junction. J. Exp. Med. 181:1995;547-557.
9. Gubler U., Chua A.D., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitsky A.G., Quinn M., Familletti P.C., Gately M.K. Co-expression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA. 88:1991;4143-4147.
10. Hohlfeld R., Kalies I., Kohleisen B., Heininger K., Conti-Tronconi B., Toyka K.V. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology. 36:1986;618-621.
11. Jeannin P., Delneste Y., Life P., Gauchat J.-F., Kaiserlian D., Bonnefoy J.-Y. Interleukin-12 increases interleukin-4 production by established human Th0 and Th2-like T cell clones. Eur. J. Immunol. 25:1995;2247-2252.
12. Kehrl J.H., Alvarez-Mon M., Delsing G.A., Fauci A.S. Lymphotoxin is an important T cell-derived growth factor for human B cells. Science. 238:1987;1144-1146.
13. Kehrl J.H., Miller A., Fauci A.S. Effect of tumor necrosis factor-α on mitogen-activated human B cells. J. Exp. Med. 166:1987;786-791.
14. Link H., Olsson O., Sun J., Wang W.-Z., Andersson G., Ekre H.-P., Brenner T., Abramsky O., Olsson T. Acetylcholine receptor reactive T and B cells in myasthenia gravis and controls. J. Clin. Invest. 87:1991;2191-2196.
15. Link J., Söderström M., Ljungdahl Å., Höjeberg B., Olsson T., Xu Z., Fredrikson S., Wang Z.-Y., Link H. Organ-specific autoantigens induce interferon-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology. 44:1994;728-734.
16. Link J., Fredrikson S., Söderström M., Olsson T., Höjeberg B., Ljungdahl Å., Link H. Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann. Neurol. 35:1994;197-203.
17. Link J., Navikas V., Yu M., Fredrikson S., Osterman P.-O., Link H. Augmented IFN-γ, IL-4 and TGF-β mRNA expression in blood mononuclear cells in myasthenia gravis. J. Neuroimmunol. 51:1994;185-192.
18. Liu C.-C., Walsh C.M., Young J.D.-E. Perforin: structure and function. Immunol. Today. 16:1995;194-201.
19. Lopez-Cortes L.F., Cruz-Ruiz M., Gomeos-Mateos J., Jimenez-Hernandez D., Palomino J., Jimenez E. Measurement of levels of tumor necrosis factor-α and interleukin-1β in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis. Clin. Infect. Dis. 16:1993;534-539.
20. Maselli R.A., Richman D.P., Wollmann R.L. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 41:1991;1497-1504.
21. Muraguchi A., Hirano T., Tang B., Matsuda T., Horii Y., Nakajima K., Kishimoto T. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for terminal differentiation of B cells. J. Exp. Med. 167:1988;332-344.
22. Nakano S., Engel A.G. Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients. Neurology. 43:1993;1167-1172.
23. Navikas V., Link H. Cytokines in the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
24. Orimo S., Koga R., Goto K., Nakamura K., Arai M., Tamaki M., Sugita H., Nonaka I., Arahata K. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromusc. Disord. 4:1994;219-226.
25. Osserman K.E., Genkins G. Studies in myasthenia gravis: review of a twenty year experience in over 1,200 patients. M. Sinai. J. Med. (NY). 38:1971;497-537.
26. Pennica D., Nedwin G.E., Hayflick J.S., Seeburg P.H., Derynck R., Palladino M.A., Kohr W.J., Aggarwal B.B., Goedel D.V. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 312:1984;452-457.
27. Rousset F., Garcia E., Defranco T., Peronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA. 89:1992;1890-1893.
28. Selmaj K., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 21:1988;339-346.
29. Selmaj K., Raine C.S., Farooq M., Norton W.T., Brosnan C.F. Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J. Immunol. 147:1991;1522-1529.
30. Shinkai K., Yoshida M.C., Maeda K., Kobata T., Maruyama K., Yodai J., Yagita H., Okumura K. Molecular cloning and chromosomal assignment of a human perforin (PFP) gene. Immunogenetics. 30:1989;452-457.
31. Somoza N., Vargas F., Roura-Mir C., Vives-Pi M., Fernandez-Figueras M.T., Ariza A., Gomis R., Bragado R., Marti M., Jaraguemda D., Pujol-Borrell R. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J. Immunol. 153:1994;1360-1377.
32. Sugihara S., Fujiwara H., Niimi H., Shearer G.M. Self-thyroid epithelial cell (TEC)-reactive CD8 + T cell lines/clones derived from autoimmune thyroiditis lesions. J. Immunol. 155:1995;1619-1628.
33. Takai Y., Wong G.G., Clark S.C., Burakoff S.J., Herrmann H. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J. Immunol. 140:1988;508-512.
34. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 13:1995;251-276.
35. Vieira P., de Waal-Malefyt R., Dang M.-N., Johnson K.E., Kastelein R., Fiorentino D.F., deVries J.E., Roncarolo M.G., Mosmann T.R., Moore K.W. Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL-10) cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA. 88:1991;1171-1176.
36. Wang Z.-Y., Xiao J., Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J. Neuroimmunol. 44:1993;209-214.
37. Wong G.G., Witek-Gianotti J., Hewick R.M., Clark S.C., Ogawa M. Interleukin-6: identification as a hematopoetic colony-stimulating factor. Behring Inst. Mitt. 83:1988;40-47.
38. Wu Z., Podack E.R., McKenzie J.M., Olsen K.J., Zakarija M. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin. Exp. Immunol. 98:1994;470-477.
39. Zhang, G.X., Yu, L.Y., Xiao, B.G. and Link, H. (1996) Enhancement of EAMG in rat by RHIL-10 is associated with augmented B cell response to AChR. IV International Conference on Cytokines. Abstract Book, p. 111.